Ipamorelin and reproductive hormone support connection on how the body manages growth and fertility
Hair loss Telogen effluvium, or temporary hair loss related to metabolic stress, is reported by a meaningful subset of patients on GLP-1 therapy
Opportunities Growing Clinical Evidence of Cardiovascular and Renal Benefits is Creating Growth Opportunities Increasing clinical evidence highlighting the cardiovascular and renal benefits of certain GLP-1 receptor agonists is significantly driving their adoption
// contain integral cofactors for collagen and keratin production, such as Vitamin C, zinc, copper, manganese, and silica, important for skin elasticity
Common considerations for CJC 1295 and Ipamorelin include: Injection Site Reactions: Mild redness, swelling, or irritation that resolves within hours
Target: 0.20 mL daily (400 mcg AOD / 200 mcg CJC / 200 mcg Ip) by Week 3